Sumitomo Pharma Co., Ltd.

About Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacture, and sale of prescription drugs, diagnostics, and over-the-counter products. Its therapeutic focus spans psychiatry, neurology, oncology, urology, cardiovascular, and metabolic disorders. Established in 1984 as Sumitomo Pharmaceuticals and headquartered in Osaka, it became a consolidated subsidiary of Sumitomo Chemical before merging with Dainippon Pharma in 2005 to create Dainippon Sumitomo Pharma. In 2022 the company rebranded to Sumitomo Pharma, continuing to leverage global R&D alliances and innovative pipelines to address unmet medical needs and improve quality of life worldwide.